drugset / Trial / NCT07248956

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

NCT07248956 ↗

Phase 2 Recruiting 116 enrolled Eye & ENT Hospital of Fudan University
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multi-center, randomized controlled, prospective clinical study.

Timeline

Start
2025-12-22
Primary completion
2027-11-30
Completion
2029-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 25 mg/m2 —
Subject Finolizumab Unknown 200 mg —
Subject Paclitaxel Small molecule 260 mg/m2 —